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Health Care Workers (HCWs) are the most vulnerable group of professionals for 
SARS-CoV-2 virus infection via airborne or direct contact. The current main three 
protective methods are PPE, training, and the hospital’s ventilations with negative 
pressure rooms. Negative pressure rooms are limited in availability in any hospital 
network. PPE and training also have the side effects of headache, skin injury and 
importantly, inconsistent donning and doffing procedures that affect the health and 
productivity of HCWs. Therefore, there is a clinical unmet need for additional modes of 
protection for HCWs against nosocomial infection. 
An aerosol hood is a partially enclosed negative pressure chamber placed around 
the head of a patient to mitigate HCWs exposure during aerosol generating clinical 
procedures such as intubation.  The optimized aerosol hood design is intended to be an 
engineering control to protect HCWs by combining a physical isolation hood with 
negative pressure system. The objective of this thesis is to1) model droplet trajectories 
and evaporation/settling rates and translate to the aerosol hood design performance; 2) to 
assess the optimized aerosol hood design performance; and 3) to evaluate the clinical 
efficacy of the aerosol hood during simulated intubation procedures. 
Droplet trajectory modeling revealed that smaller droplets evaporate within 5 
seconds in the aerosol hood and would get cleared by the negative pressure system, while 
larger droplets would follow an exhaled jet path impacting inside the aerosol hood. An 




Exchange Time, and Air Changes per Hour (ACH). At a half power blower setting, the 
particle penetration resulted in 10-4 with a corresponding protection efficiency of 99.99%. 
The aerosol hood has an average Air Exchange Time of 2.76 minutes for a 99.9% 
reduction using a half power blower setting and an average of 151.44 Air Changes per 
Hour (ACH). The clinical efficacy was studied in a simulated intubation procedure by 
measuring the aerosol exposure in the room and particle deposition on the participants’ 
PPE. Bedside location to the SIM-man had a higher particle concentration exposure than 
a background location, however, when the negative pressure system aerosol hood is used, 
the bedside location has a lower particle concentration similar to the background 
exposure. Particle deposition decreased by 42% for the face shield and gowns: and 32% 
increase on the gloves when measuring the on participants’ PPE substrate.  
Overall, the optimized aerosol hood design has a high performance in clearance of 
human respiratory droplets and aerosols due to its design feature of a physical isolation 
and negative pressure system. The clinical study has shown the efficacy of the aerosol 
hood technology and promising in supplementing PPE and hospital’s negative pressure 
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Chapter 1: Introduction  
1.1. Background 
During the COVID-19 pandemic, the subject of infectious disease transmission via 
aerosols has become an increasingly important topic. After 2002-2003 SARS-CoV-1 
outbreaks, a number of studies were conducted on the risk of transmission of respiratory 
infections, the impact of hospital ventilation, and identifying aerosol generating clinical 
procedures to minimize nosocomial infection to Healthcare Workers (HCWs) [1, 2]. 
However, a concern for SARS-CoV-2 virus transmission via aerosol routes has made clear 
that prior studies have not (1) fully clarified to what extent aerosol based disease 
transmission occurs for SARS-CoV-2 and (2) enabled the development of technologies to 
mitigate aerosols based infection.  
Prevention controls for SARS-CoV-2 virus still heavily depend on Personal 
Protective Equipment (PPE) and HCW training [9, 10, 13, 14, 15]. However, inconsistent 
use of PPE and improper donning and doffing are common issues among HCWs that 
increases the likelihood of infection transmission. Evans et al. discusses a new role of 
‘dofficer’ to ensure standard adherence to PPE procedure [9]. While that mitigates the 
concern of improper use of PPE, donning is laborious activity as shown in Figure 1 [32]. 
Moreover, recent studies showed a skin injury and headache associated with an increased 





Figure 1: Donning Procedure for HCWs as a PPE before caring for COVID patients [32]. 
 
Although PPE and administrative controls are mandatory protection modes, the 
associated side effects and inconsistent use can impede HCWs’ health and productivity. 




of prolonged and frequent PPE use. According to the Center of Disease Control (CDC) 
Hierarchy of Controls (Figure 2), PPE and Training are the lowest level of disease control 
protection [11, 13, 14]. 
 
Figure 2: CDC’s Hierarchy of Controls showing PPE and Administrative controls such as 
training, scheduling and in person monitoring being a lower level of controls [11]. 
 
There are not many engineering controls measures, which is the next level of 
control per CDC, designed and properly tested to protect HCWs from infectious disease 
transmission such as SARS-CoV-2 virus. Considering COVID-19 virus long term 
presence, a robust engineering control that can outlast the pandemic and bring relief to 
HCWs daily PPE requirement is a current unmet clinical need. The first step in tackling 
the unmet clinical need is to understand the relations between the aerosol principles of the 
respiratory droplets. The aerosol principles that are of interest in this study are droplet 




fluid velocity for respiratory droplets generated during clinical procedures such as 
intubation. [3 - 8, 31].  
Numerous articles have been published related to droplets dispersion and 
evaporation rate based on a jet model, physics-based numerical model, and Computer Fluid 
Dynamics (CFD) simulation [ 3, 7, 8]. Such studies facilitate the development of effective 
prevention controls for SARS-CoV-2 virus [7, 8], and technological developments based 
on aerosol engineering principles. Xie et al., used a non-isothermal jet model to recreate 
the Wells Evaporation and Falling curve that plots an evaporation and settling rates as a 
function of the diameter size [7]. Tang et al. discussed how the large droplets fall to the 
ground quickly and small droplets stay and follow the air flow current. In addition, it 
discussed the influence of hospital ventilation systems on the droplets path by containing 
or dispersing. 
The hospital ventilation systems with a negative pressure rooms are the third 
prevention control for nosocomial infection [1, 2, 8]. Advanced mechanical ventilation 
systems with filtration reduce the risk of airborne transmission compared to conventional 
ventilation systems [2]. Current conventional ventilation systems will typically need at 
least a minimum of 15 minutes of air clearance time between surgical procedures [8] per 
CDC guidelines of 99.9% reduction of the particles produced during the procedure must 
be cleared via ventilation before preparation for a new procedure can commence. Walker 
et al. discusses how a negative pressure isolation in hospital rooms reduces aerosol 
transmission, which is one of the supportive studies towards the aerosol hood’s negative 




in many hospital networks, and furthermore, can be problematic to deploy for 
immunocompromised patients, where positive-pressure environments are desirable.  
  
Figure 3: Negative pressure room in the hospital image and air flow schematic.   




As an engineering control to both provide additional protection to HCWs and to 
reduce clearance time needed between procedures, an aerosol hood was recently designed 
[24]. An aerosol hood is a partially enclosed negative pressure chamber designed to 
mitigate health care worker aerosol exposure during potentially aerosol generating clinical 
procedures such as intubation. The aerosol hood (Figure 4) is composed of HEPA filter, 





aerosol hood has cord inlets and strap hook system to secure it with an inclined hospital 
bed position. 
Figure 4: Optimized aerosol hood design. 
The negative pressure system is created by connecting the HEPA filter with a 
blower using a duct tube as shown on Figure 5. When the blower is turned on the air flows 
into the aerosol hood and transport the patient's respiratory droplets through the HEPA 





Figure 5: Aerosol hood connected with the blower to create the negative pressure system.      
There are several aerosol hood designs with different naming conventions, such as 
the Aerosol Box, Containment Device, Safety Tent, and Aerosol Containment Device [15-
23]. The common aspect of all designs have a physical isolation like a hood/box and it has 
an opening for HCWs to insert their hand for intubation procedures. Some designs have a 
suction system either using a vacuum/filter or temporary container [19, 25]. The main 
distinction of the aerosol hood design from others is the addition of High Efficiency 
Particulate Air (HEPA) filter and the silicone rubber sheet covered iris ports that prevent 
aerosols from escaping the aerosol hood. The aerosol hood was designed and patented in 




is a continuation of the initial design optimization based on Physicians and HCWs feedback 
and usability experience.   
1.2. Overview of Dissertation 
This thesis describes a combined laboratory and medical simulation clinical study of 
a negative pressure aerosol hood to mitigate aerosol-based disease transmission to 
healthcare workers.  In this introductory chapter, the importance of developing engineering 
controls to prevent infection of health care workers via aerosols routes has been first 
discussed.  The second chapter reviews the current state of knowledge on droplet and 
aerosol particle trajectories and residence time produced from human respiratory droplets.  
The remaining chapters focus on discussion of the studies performed, including design of 
the protective hood, laboratory testing, and medical simulation testing. 
 
Chapter 2: Current State of Knowledge on Respiratory Droplets Trajectories and 
Residence Time 
Chapter 3:  Optimized Aerosol Hood Design and Efficacy as an Engineering Control to 
Protect HCWs 
Chapter 4: Simulated Intubation Procedure in a Simulated Hospital Setting to Assess 




Chapter 2: Current State of Knowledge on Respiratory 
Droplets Trajectories and Residence Time  
2.1. Preface 
Understanding respiratory droplet trajectories and residence times are critical in 
designing effective engineering controls for protection against aerosol-based disease 
transmission. The objective of this study was to utilize a model of respiratory droplet 
trajectory, including evaporation and settling rates to understand how an aerosol hood can 
be designed to mitigate dispersion of such droplets.  Specifically, an isothermal jet model 
was used based on Xie et al. [7] that provided the fluid velocity and evaporation rate 
equations. The particle velocity was calculated based on the Verlet algorithm and, unique 
from Xie et al [7], a head tilt angle was incorporated in the model. The droplet trajectory 
model resulted in a critical diameter size near 65 μm traveling up to 0.3 meters before 
evaporation. Smaller particle diameter size, which evaporate to sub-micrometer particles, 
will be cleared by the half power blower setting with a 62-cfm flowrate of the aerosol 
hood. The evaporation and settling curves showed in a maximum of 30 seconds 
evaporation/settling rate for the critical diameter size of 65 μm.  Smaller diameter size 
will be evaporating within 5 seconds and again will be cleared by the flowrate created in 
the aerosol hood. For large particles follow through a jet path leading to impaction inside 




effectiveness of the aerosol hood in capturing small and large particles either by the air 
flow streamlines or impaction to the aerosol hood.  
2.2. Introduction 
Droplets are generated from the respiratory tract and are introduced into the 
environment through normal breathing, talking, coughing, and sneezing [3, 4, 26]. The 
breathing rate, relative humidity and opening diameter of the respiratory jet determines the 
evaporation rate and droplet trajectory [7]; all these ultimately determine the size 
distribution of potentially infectious particles produced from human respiratory droplets. 
Higher velocity droplet generating events, such as sneezing, produce higher concentration 
and smaller droplets [4, 7]. Droplets generated by normal breathing are at lower 
concentrations [3, 4].  While this suggests sneezing would be of greater concern, it is 
important to note that breathing is continuous, while sneezing (and similarly coughing) is 
comparatively rare, hence the majority of droplets produced by an individual come from 
regular breathing activities (along with speaking).  
The parameters governing droplet size and generation rate continue to be debated, 
as do the relevant droplet size ranges for which (1) rapidly settle to the ground, and (2) 
evaporate, yielding small particles with long airborne residence time. A recent article by 
Vuorinen et al. considered large droplets for sizes greater than 100 𝜇m, small droplets 
between 5-100 𝜇m sizes and droplet nuclei for sizes less than 5𝜇m [7].  Droplet nuclei are 




Meanwhile large droplet residence time are 2-20 seconds, while small droplet residence 
time are 20 sec – 1hr [7].  
Beyond coarse size classifications, the physics of droplet migration and evaporation 
can be examined to understand droplet/particle residence time.  This is in fact more 
important than size classifications, as the size of a droplet which evaporates to a droplet 
nuclei size is dependent on the environment (i.e. relative humidity).  Historically, the Wells 
Evaporation-Falling curve is utilized to understand the relationship between droplet size, 
evaporation and settling rate. The original Wells curve was developed in 1934, and is 
shown in Figure 1 below. The x-axis is the droplet diameter, as expelled from an individual, 
and the y-axis is the time it takes to either evaporate or settle to the ground (the smaller of 
the two values). The first part of the curve (on the left side) shows (starting from 0 x-axis 
to 160 um) the time it takes for a droplet to evaporate. The second (from 160 – 200 um) 
and third (from 140 – 200 um) curves (on the lower right side) show the time it takes for a 
spherical droplet to reach on the ground from 2 meters height, leading to an inflection point 
before which droplets lead to particles with infinite residence time in an aerosol, and after 
which they have finite residence time determined by gravitational settling. Importantly, the 
Wells Evaporation-Falling curve also yields a critical droplet diameter (critical size), i.e. 
the droplet diameter where the settling time and evaporation time coincide, for the given 





Figure 1: The Wells Evaporation-Falling curve developed in 1934. A curve that plots a 
relationship between evaporation rate, settling (falling) rate and particle diameter size. 
Reproduced with permission from [7]. Permission is included in the Appendix A, Figure 
S1. 
 
         However, the original Wells curve did not consider droplet trajectories, the 
surrounding air movement and the jet produced by respiratory droplets [7]. Therefore, 
following the work of Wells, Xie et al. refined evaporation and falling curves to not only 
determine droplet residence time but also model their trajectories either to deposition or 
until complete evaporation (where they are assumed to yield residual aerosol particles) [7]. 
This thesis uses the models laid out on Xie et al. to confirm the droplets generated by 
patient laying under the aerosol hood would have (1) trajectories leading beyond the hood 
if the hood was not present or (2) would yield aerosol particles which would be dispersed 
through the room in the absence of the hood.  The development of this calculation 
procedure also results in a droplet trajectory spreadsheet, whose output tables are included 




supporting information.  The spreadsheet is formatted in a way to enable those unfamiliar 
with droplet trajectory calculations to utilize it to understand droplet trajectories and 
evaporation in a healthcare setting.       
2.3. Calculation Methods 
To construct an improved Wells Evaporation-Falling curve, Xie et al. presented 
both cases of non-isothermal and isothermal jet models for the droplet trajectory from the 
respiratory droplets [7]. In this thesis, the Xie et al model is largely followed, but an 
isothermal jet model is used assuming a minimal temperature difference between the 
respiratory tract and surrounding environment. The schematic below (Figure 2A) from Xie 
et al. shows the isothermal jet model that has a similar trajectory to a human sneeze jet 
shown on Figure 2B from Tang et al [7,8]. 
Figure 2A: Isothermal Jet Model from the Xie et al. reproduced with permission from [7]. 





Figure 2B: A human sneeze jet model showing the trajectory of respiratory droplets. 
Reproduced with permission from [8]. Permission is included in the Appendix A, Figure 
S2. 
 
Not only are the respiratory droplets visible in the jet but also one can see how the large 
droplets settle more quickly to the ground while the small droplets remain suspended as a  
cloud that would stay in the air and eventually evaporate, leaving aerosol particles. To 
quantify the critical size of the droplet diameter (i.e. the droplet size where it changes from 
evaporating to settling) and the droplet travel distance, two calculation steps were taken; 
each is adapted from the model of Xie et al [7]. The first step is to find droplet and fluid 
velocity and the second step was determining the evaporation rate of the droplets. 
(1) Particle and Fluid Velocity: The two main forces that act upon a settling droplet are the 




on the particle Reynolds Number (𝑅𝑒 ) and Drag Coefficient (𝐶 ) that are shown in 
Equations (2) and (3).  
𝐹 = 𝐶  𝜌 (𝑢 −  𝜈) 𝜋𝑑
 
                                                                                (1) 
𝑅𝑒 =  
( )
                                                                                         (2)                                                             
𝐶 =  1 + 𝑅𝑒
/               𝑅𝑒 ≤ 1000                                                                  (3)     
The fluid velocity was calculated for both Streamline coordinates (s, r) and 
Cartesian coordinates (x,y) using Equations (4) – (9). Equation (8) and (9) incorporate 
angle in trajectories of the fluid velocity to simulate patient’s head movement in the aerosol 
hood. 𝜃 is the head tilt angle from the centerline position of the patient. Positive degree is 
head tilted up representative of a patient head position during the intubation procedure. 
Negative degree refers to the head tilted down representing possible head movement by the 
patient before or after the intubation procedure.  
𝑈 =  6.8𝑈 /ŝ                                                                                                                   (4) 
 ū𝑠 =  𝑈𝑚𝑠𝑒𝑐ℎ2(𝜎ɳ)                                                                                                         (5) 
ū𝑟 =  𝑈 [
( ( )( ) )
( )( ( )( ) )
]                                                                                    (6) 
 
                                                                                                                                          (7)  
 
𝑢 =  𝑢𝑠 𝑐𝑜𝑠 𝜃 +  𝑢𝑟 𝑠𝑖𝑛 𝜃                                                   (8) 
𝑢 = 𝑢  𝑐𝑜𝑠 𝜃 +  𝑢  𝑠𝑖𝑛 𝜃                                                                                                 (9) 
 




 Where 𝑈  is centerline velocity decay, which is a function of the initial velocity 
(𝑈 ) and normalized streamline axial distance ( ?̅?). The axial and radial fluid velocity used 
constants such as σ=10.4, a = 0.0046 and b=0.0075. 𝜂 is also the ratio between the 
normalized streamline radial distance (?̅?) and the normalized streamline axial distance ( ?̅?). 
The Verlet algorithm equations (10) and (11) were used to calculate the droplet position 
using the droplet acceleration, droplet velocity and a time step (𝑡)[39]. Mass (𝑚 ), 
acceleration (𝑎) and particle velocity (𝑉 ) equations (12) – (14) were used for the Verlet 
Algorithm.                                                    
𝑥(𝑡 + ∆𝑡) = 𝑥(𝑡) +  𝑉 (𝑡)𝛥𝑡 + 𝑎 (𝑡)𝛥𝑡                                                                      (10) 
𝑦(𝑡 + ∆𝑡) = 𝑦(𝑡) +  𝑉 (𝑡)𝛥𝑡 + 𝑎 (𝑡)𝛥𝑡                                                                     (11) 
𝑚 =                (12) 
𝑎 =     and 𝑎 =  − 9.81𝑚/𝑠                                                                   (13)                                                           
𝑉 =      and 𝑉 =                                                                              (14) 
(2) Evaporation rate of the droplet: The above Equations (1) - (14) can be solved to model 
the trajectory (the x and y positions of droplets over time) of a fixed diameter particle 
ejected from a jet and subject to gravity, with the particle’s inertia accounted for and the 
jet fluid velocity.  For solid particles, this approach is highly accurate in predicting droplet 
motion in the absence of diffusion, i.e. larger super micrometer particles in flowing 
systems.  However, droplets rapidly evaporate in most environments including indoor 




velocity, diffusive mass transfer limitations, and temperature. These factors were 
incorporated into the Schmidt number (𝑆𝑐) and Sherwood number (𝑆ℎ) correlations shown 
in equations (15) and (16), and used to compute the evaporation rate. The Schmidt number 
is the ratio of momentum diffusion to mass diffusion. The Sherwood number is the ratio of 
convective mass transfer to diffusive mass transfer. The 𝐷 in Equation (15) is the binary 
diffusion coefficient of vapor through air.  
𝑆ℎ = 1 + 0.3𝑅𝑒𝑝 𝑆𝑐                                                                                                                   (15) 
The radius change rate  can be calculated using Equation (17) and the diameter change 
𝑑   evaporation is calculated using Equation (18) below.  
= ln                                                                                              (16) 
 
                                                                                                                                         (17) 
 
Where 𝐶 is correction factor of temperature affecting the diffusion; 𝑀  is the 
molecular weight of the vapor; 𝑅 is the constant gas for water pressure; 𝑝 is the total 
pressure and 𝑝  is the vapor pressure. The important parameter from equation (16) is the 
𝑝 , where the vapor pressure is multiplied with the Relative Humidity (RH) to represent 
the desired humidity level of the hospital room setting. In this thesis 50% RH in most 
calculations, unless it is stated. 







2.4. Results and discussion:   
2.4.1. Droplet Trajectories:  
The droplet trajectories for diameter sizes of 50 μm, 100 μm, 150 μm and 200 μm 
were analyzed at four upward head tilt positions, 0 degrees, 15 degrees, 30 degrees and 45 
degrees.  The initial straight line shown Figures 3 and 4 refer to the droplet jet trajectory. 
When the jet changes direction, particles “fall out” of the jet and stop moving and either 
evaporate or settle on the ground once they exit the jet.  Figure 3 shows as the droplet 
diameter size increases, the droplet travels longer distances. In the case of 50 μm diameter 
size, the droplet quickly evaporates before reaching the ground. For the rest of the diameter 
sizes, the settling distance increased approximately by 0.3 meter for every 15 degrees. The 
head tilt angle shown on Figure 3 are centerline (0 degrees) and upward tilt (+ degrees), 
where the higher the degree of tilt, the droplet horizontal settling distance is shorter and 






Figure 3: Droplet trajectories for variable size droplets and variable upward head tilt angle. 
A diameter of 50 um evaporates before reaching the ground. The rest of bigger diameter 
sizes fell off the jet trajectory and settled on the ground from a height of 2 meters. 
 
The clinical relevance of an upward head tilt is the patient’s head must be tilted to 
variable levels in hospital settings. Larger droplets with higher upward tilt angles should 
impact the hood because of travel distance.   In the meantime, the downward head tilt is 
important to understand as the patient can look down occasionally. Figure 4 below shows 
the trajectories symmetry effect when the head tilt is upward or downward. It also shows 
the horizontal traveling distance remains the same with slight variation where the upward 
head tilt trajectory settles quickly, followed by the downward head tilt and the centerline 





Figure 4: Droplet trajectory of an upward (+ degrees) and downward (- degrees) head tilt.  
Upward head tilt represents the patient’s head movement for the intubation procedure. 
Downward head tile represents the patient’s head movement before or after intubation 
procedure. 
 
The droplet trajectories were used to estimate the Aerosol Hood capability in 
capturing the small and large droplet trajectories generated during intubation procedure. 
Figure 5 below shows an overlay of Manikin laying in the aerosol hood and droplet 
trajectory of Figure 4 rotated 90 degrees in CCW (diameter size: 190um, and head tilt -30 
degrees, 30 degrees and 0 degree). The approximate distance between patient mouth 
opening and the aerosol hood filter is approximately 0.4 meters (15 inches). The droplet 


















Figure 5: Hypothetical overlay of Manikin in an aerosol hood and vertical distance of 
droplet trajectory. The distance between the patient's mouth opening to the filter is 
approximately 0.4 +/- .1 meters. Large droplets (greater than the critical diameter size of 
60 – 70 um) start falling off the jet after 0.3 meters for 65 um to 1.2 meters for 200 um, 
which is beyond the distance of the filter location. Smaller droplets would evaporate shortly 
after exiting the patient’s mouth and carried towards by the streamline of the aerosol hood 
negative pressure system.  Note the droplet trajectory simulations are performed for angles 
closer to perpendicular to gravity than depicted. 
 
Droplet trajectory models for respiratory droplets, including those critically 
examining the 6ft rule distance during COVID pandemic in 2020-2021, depend strongly 
on the jet model [31, 37]. While not the focus of this work, these trajectories show that 
future work on better quantification of the jet expelled during human respiratory droplets 
would be necessary.  To date, respiratory jets have been largely modeled using a “constant 
exhale” approach, which is of course not an accurate description of human breathing 
patterns.  In the moment when droplets “fall out” of the jet strongly affects their ultimate 
 








penetration distance into space, transient breathing models will be important to consider in 
the future. 
2.4.2. Evaporation and Settling Curve: 
The evaporation and settling curve connect the two phenomena of evaporation rate 
and settling rate in one graph plotted on a diameter size vs. time. The phase change between 
evaporation and settling time is the critical diameter size that differentiate between the 
small and large droplets for a given jet model and physical boundary conditions. The above 
Figure 6 shows the inflection point occurred at critical diameter size of 65 μm  and 30 
seconds at 50% Relative Humidity (RH) and 0 degrees (no head tilt). Based on our 
isothermal jet model, all other sizes evaporate or settle on the ground in less than 30 
seconds. Diameter smaller than 65 μm evaporates within 0.3 meters of the beginning of the 
trajectory. Diameter larger than 65 μm settles to the ground up to 1.2 meters (in the case of 
200 μm). Inside the aerosol hood, the distance between the patient's mouth and top panel 
where the filter is measured is approximately 0.4 meters. Given the flowrate of 64 cfm at 
a half power blower setting inside the aerosol hood small particles that would evaporate 
right away will be carried by the air flow streamlines. Larger particles will still be in the 
jet pathway beyond the HEPA filter. In the case of large droplets that fell off the jet path, 





Figure 6: Evaporation and Settling Curve at Relative Humidity (RH) 50%. The upward 
head tilt delayed the settling time by 30 seconds although it would travel a shorter distance 
than the centerline head position or downward head tilt. The upward head tilt had no effect 
on the evaporation rate of the particles.  
 
Figure 6 also shows a change in angle from 0 degree to 30 degrees and the settling 
time difference of an average of 1.4 seconds longer for the 30 degrees head tilt degree. 
However, the evaporation rate and the critical diameter of 65 μm did not change. The 
difference between the centerline and upward head tilt is statistically insignificant (p-value 
0.7).  
Besides the head tilt angle, the impact of relative humidity has been assessed on its 

























The typical SARS-CoV-2 virus is around 0.1 μm [38]. However, during droplet 
formation in a human respiratory tract, a wide range of droplets sizes are created [31].  The 
negative pressure system with a flowrate around 62 cfm will be able to maintain the jet 




Droplet trajectories and residence time have been assessed based on current 
knowledge. Isothermal jet model was used to evaluate the effectiveness of the aerosol hood 
design to contain both small and large droplets. Following existing literature, droplet 
trajectory was calculated with a head tilt angle incorporated. The evaporation rate for the 
diameter change was also calculated that produced the evaporation and settling curve 
similar to Wells Evaporation and falling curve. The following conclusions were drawn: 
1.  The SARS-CoV-2 virus diameter size is around 0.1 μm [38], however, respiratory 
droplets can be as large droplets as 100 μm [31]. The 62-cfm flow rate of the half power 
blower setting will clear small droplets below the critical diameter size of 65 μm within 
seconds. While larger droplets would follow an exhaled jet path impacting inside the 





2.   The evaporation and settling curve shows a critical diameter size of 65 μm at a time of 
30 seconds. The head tilt angle has a non-significant impact on settling rate where a 30 
degrees change resulted in an average of 1.4 seconds longer settling rates than a 0 degree.  
2.6. Supplementary information  
List of information available in Appendix A: 
- Author’s publication permission for Reference 7 and 8 in Figure S1 – Figure S2. 
- Isothermal model inputs and calculation steps of the spreadsheet in Figure S3 – 












Chapter 3: Optimized Aerosol Hood Design and 
Efficacy as an Engineering Control to Protect HCWs 
3.1. Preface 
A previous design of the aerosol hood was optimized to incorporate physician’s 
feedback. The objective of this study is to assess the optimized aerosol hood design 
performance. The major design changes were the widening of the front panel opening and 
the use of a smaller HEPA filter (12 in. x 12 in.) than the previous HEPA filter (24 in. x 24 
in.). Design features that were added to the optimized aerosol hood were iris ports, cord 
inlets, hospital bed straps. The air speed and noise level of the aerosol hood were measured 
and compared against known government guidelines. The flow rate profile showed a 
maximum of 0.8 mph (0.4 m/s) air flow rate in the aerosol hood which is equated to a calm 
wind based on Beaufort Number. The noise level for inside and outside of the hood for half 
power blower setting is under the NOISH recommended noise exposure limit of 85 dBA. 
The aerosol clearance time was used to calculate the air exchange time of the aerosol hood 
for a 99.9% reduction time. An average of 2.76 minutes air exchange time was observed, 
which is faster than the current 15 minutes air exchange time required for a 99.9% reduction 
time in many operating rooms. The particle penetration was calculated using a particle size 




A particle penetration of 10-4 with a corresponding protection efficiency of 99.99% was 
achieved for a half power blower setting.  
Overall, the air flow and noise level inside the aerosol hood ensures in maintaining 
the patient's comfort inside the hood. The optimized aerosol hood design performance by 
a HEPA filter protection efficiency of 99.99% combined with an average air exchange time 
of  2.76 minutes (for 99.9% reduction corresponding to effective 151.44  air changes per 
hour, ACH), gives confidence in additional protection to HCWs from disease transmitting 
aerosols such as COVID-CoV-2 virus. 
3.2. Introduction 
The current infection protection modes (i.e. PPE, training, ventilation systems) in 
the hospital for HCWs are associated with side effects such as headache, skin injury and 
inconsistent application of the donning and doffing procedures. To address the unmet need, 
the aerosol hood was initially developed including a HEPA filter and blower [24]. After a 
limited use in hospitals, physician’s feedback was collected for an improvement on the 
design. The previous design had a smaller front panel opening and one of the feedback was 
to widen the front opening to accommodate larger size patients more comfort [24]. Hence, 
the aerosol hood design was optimized from the previous design by widening the front 
panel opening, additional iris ports on the sides, minimizing the HEPA filter size, adding 
cord inlets and hospital bed straps. With the new design, the front opening is maximized to 
better fit a wide range of patient body size. The iris ports have been doubled on the 




of the back panel are intended for the primary HCW to reach the patient lying inside the 
hood. The iris ports on the side panels are intended for a support HCW to assist the primary 
HCW. The previous 24 in x24 in HEPA filter had a weight of aerosol hood up to 40 lbs, 
therefore, minimizing the HEPA filter footprint to 12 in x 12 in was essential to reduce the 
weight without compromising the protection efficiency. Adding cord inlets at the bottom 
center of the aerosol hood sides was intended to pass through any device cords needed for 
the patient while laying inside the aerosol hood. This also prevents HCWs using the iris 
ports as a cord inlet, which will not only wear out the iris ports, but also create a leak of 
aerosol particles out of the aerosol hood. The optimized aerosol hood has bed straps to 
secure the aerosol hood with the hospital bed using a hook system. In the event of inclining 
the hospital bed is desired, the straps will keep the aerosol hood secure on the inclined 
hospital bed. 
The optimized aerosol hood performance was assessed in a standard laboratory 
environment where a BLAM Nebulizer was used to aerosolized droplet diameters sizes of 
1-3 𝜇m, which is in alignment with references for exhaled air particle sizes [4, 5]. The 
solution used to form aerosol was a 25ml of 20% Glycerol and DI water mix. The air speed 
and flow rate of the aerosol hood were characterized to determine the physical sense of the 
airflow on the patient during the Blower On setting that creates a negative pressure system. 
Furthermore, particle penetration and aerosol clearance time were evaluated to assess the 




3.3. Experimental methods 
Optimized Aerosol Hood Design: The aerosol hood was optimized from the previous 
design by widening the front panel opening, additional iris ports on the sides, reducing the 
HEPA filter size, adding cord inlets and hospital bed straps as shown on Figure 1 below. 
For the optimized design, the front panel opening width is 25.5 in. (65 cm) and the height 
is 15.1 in. (38 cm), which is 10 cm wider than the previous design.  
   
Figure 1: Aerosol hood design comparison between the previous design (left) and the 
optimized design (right) based on HCWs feedback. The optimized design has wider front 
panel opening, smaller HEPA filter footprint and more iris ports on the side panels. All 
dimensions are in inches. 
 
Two 7 in. diameter 2-layer iris ports (with silicone rubber sheet) are placed on all sides of 
the hood to enable hand easily inside the hood. The HEPA filter unit has been reduced from 
a 24 in. x 24 in. to 12 in. x12 in to allow visibility from the top panel and minimize the 
weight of the hood without compromising filter efficiency. The optimized hood comes with 





been incorporated on both side panels bottom center to allow for device cord passage that 
is needed for the patient during clinical procedures.  
 Aerosol Hood Set Up: The aerosol hood set up consisted of a HEPA filter, a blower, and 
aerosolization method as shown in Figure 2 below. The HEPA filter was mounted on top 
of the aerosol hood inside a clear polycarbonate filter holder. A 4 in. diameter (0.25 in. 
wall thickness) and approximately 5 ft. long circular duct was used to connect the filter 
holder to the blower. An 8-speed setting blower (AC Infinity CLOUDLINE S8) with a 
diffuser was used to create the negative pressure system by withdrawing air from the 
aerosol hood.  
 
Figure 2: Schematic diagram of the aerosol hood set up to measure the protection 
efficiency of the blower-HEPA filter system. The aerosol hood connected with a blower 







The aerosolization method used an 8-Jet BLAM Nebulizer with 20% glycerol and 
DI water in a 1:5 ratio. The nebulizer used compressed air to convert the liquid solution to 
an aerosol. Then the compressed air was regulated using a valve and a pressure gauge. The 
operating pressure of the nebulizer was correlated with the flow rate on a characterization 
data plot provided with the nebulizer. 30 psi operating gauge pressure was used that 
resulted in 15 L/min. flow rate of aerosol. The 8-Jet BLAM Nebulizer produced particles 
in the 0.5 – 3 𝜇m size range. An outlet tube is fitted to the inlet of the nebulizer and placed 
at the center of the hood in an upward position in the case of a research lab. In the case of 
the M Simulation Lab of the University of Minnesota, the outlet tube was connected to the 
mannequin (SIM-man) esophagus to simulate a breathing pattern through the mouth. 
Along with the aerosol hood set up, an air scrubber was used in the background to 
reduce the number of particles in the testing room. In the research lab, the use of an air 
scrubber reduced the particle number of the room by 95% after running the air scrubber for 
10 minutes. In the M Simulation Lab of the University of Minnesota, the reduction in the 
particle number was 38% after 10 minutes, due to the clean room nature of the M 
Simulation Lab (i.e. the room was already low in particle concentration in comparison to 





Aerosol Hood Characterization: The flow rate measurement was conducted to assess the 
uniformity of incoming air (1) at the front opening of the hood, (2) directly under the filter 
of the top panel of the hood and (3) inside a 6 in. diameter duct using the Log Tchebycheff 
method. For the front opening of the hood (17 in. x 24 in) (see Figure 3 below) and directly 
under the filter (12 in. x12 in.), the flowrate and velocity were measured using VelociCalc 
at nine equidistant grid-type locations. Starting from the top left corner as a datum, 60 
consecutive 1 second tests were collected. 
Figure 3: Nine equidistant locations of the front opening of the aerosol hood for flow rate 
measurement. 
 
The average velocity of the aerosol hood was calculated from the flowrate and 
compared to the wind speed Beaufort number from weather.gov website [27] to determine 
the comfort level of the air speed for the patient that would be laying in the aerosol hood.  
In addition, the level of noise in the aerosol hood was measured using Digi-Sense Data 




was used to measure the noise level (because of availability), which is the worst case as it 
has a HEPA filter 24 in. x 24 in. 4 times bigger than the optimized aerosol hood design. 
The sound measure was taken at a single location at the center inside the hood and three 
locations at left, right, back outside the hood. 
Aerosol Clearance Time: The particle concentration clearance time was tested in two 
environments: (1) in a Research Lab and (2) in a M Simulation Lab of the University of 
Minnesota. The Research lab testing showed the potential of clearance time without the 
interference of human factors; the transit time to the measurement instruments was 
minimized and data collection was automated. The M Simulation Lab was representative 
of clinical setting with the clearance time being impacted by human intervention to make 
the measurement and by tubing lengths to instruments, which would likely be the case for 
workers testing a product.  In a research lab using a Laskin nozzle aerosol generator (ATI 
Model 4B, Owings Mills, MD) instead of the 8-Jet BLAM Nebulizer and Condensation 
Particle Counter (CPC, Model 3025A, TSI inc. Shoreview MN) instead of OPS. A sample 
was run for each blower settings (Half Power and Full Power) for 5 minutes continuously. 
In the M Simulation Lab, an 8-Jet BLAM Nebulizer was turned on for 5 seconds in the 
hood then turned off, which filled the hood with visible smoke. Then, the blower was turned 
on along with an Optical Particle Sizer (OPS, TSI Model 3330) to record the time it took 
for the blower to suction all the aerosol particles released for 5 seconds. A single sample 
consisted of 1 second data acquisition of 300 samples (5 minutes in total). Two blower 
settings, Setting 4 (Half Power) and Setting 8 (Full Power) were used to collect three 




Air Exchange Rate and Time: The air exchange time corresponds to the time required for 
99.9% reduction in aerosol concentration following a “burst” of aerosol generation, 
coinciding with the CDC determined clearance time required for operating rooms [28]. To 
determine the air exchange time, the characteristic time for clearance (𝜃) is calculated using 
Equation (1) below. Second, the air exchange rate (units of inverse time) at which air is 
cycled through the hood is calculated using Equation (2).  It is parameterized through a 
plot of particle concentration versus time for experiments where the aerosol is introduced 
prior to aerosol hood operation. The slope of the plot was inversely proportional to the 
negative value of 𝜏, which is the time constant. Finally, the air exchange time is calculated 
by multiplying 𝜏 with the natural log of 0.001 (for a 99.9% reduction time greater than 
CDC requirements) using Equation (3). 
𝜃 (𝐶ℎ𝑎𝑟𝑎𝑐𝑡𝑒𝑟𝑖𝑠𝑡𝑖𝑐 𝑇𝑖𝑚𝑒) =𝑙𝑛
   
  –  
                            (1) 
𝑆𝑙𝑜𝑝𝑒 =  −1/ 𝜏                                                       (2) 
𝐴𝑖𝑟 𝐸𝑥𝑐ℎ𝑎𝑛𝑔𝑒 𝑇𝑖𝑚𝑒 =  −𝑙𝑛 (0.001) ∗  𝜏 = 6.908 ∗  𝜏             (3) 
Where the Particle Concentration is the number of particles per volume (#/cm3) 
when the aerosol was turned on with the blower off. The Background Concentration is the 
number of particles per volume (#/cm3) with no aerosol turned on but with the blower 
turned on and Maximum Concentration is the highest concentration value from the Particle 
Concentration used as a constant.  Correspondingly the air changes per hour (ACH) is 
calculated as: 





Particle Penetration Calculation: The particle penetration (𝑃) on Equation (5) is the ratio 
of the particles outside the hood to the inside of the hood while the aerosol is turned on. 
Where measurements consisted of a size distribution measurement of the outside of the 
hood with an aerosol generator turned on and a blower turned on (Oon) and inside the hood 
with an aerosol generator turned on and  a blower turned on (Ion ).  
𝑃 =  (𝑂  )/(𝐼 )                                                                                                              (5) 
An outside of the hood background air measurement (Ooff) was also collected on 
the right, left and front sides, which were all overlapping [Suppl Figure 1]. Inside of the 
hood, the 6 locations were center (C), center 1 (C 1)(slightly to the right of the center), 
center 2 (slightly to the left of the center) (C 2), left (L), right (R) and front (F)as shown on 






Figure 4: Location of particle penetration measurements on the aerosol hood set up. 
All measurements were taken at a height of 10 in. from the bottom surface of the 
aerosol hood, which is the iris ports center as the worst-case condition where aerosol 
particles could escape. The aerosol generator outlet was 6 in. high at the center of the hood 
in both cases of the research lab set up and in the case of SIM-man. For the SIM-man, the 
aerosol was connected to the esophagus tract and through the mouth (i.e. approximately 6 
in. in height). 
 
3.4. Results and Discussion:   
3.4.1. Level of Air Speed and Noise 
The air speed and noise inside and outside of the hood are important for the patient 
and the HCW. The air speed ensures that the patient is not experiencing a high flow rate 




The flowrate of the aerosol hood front panel opening had an average of 133 cfm 
(cubic feet per minute, where 1 cfm = 1.7 m3 hr-1, used here as cfm is the most commonly 
used unit for ventilation rates in the United states) for a full power (Setting 8) and an 
average of 62 cfm for a half power (Setting 4) [Suppl Table 4]. Similar data was achieved 
for the flow rate directly under the HEPA filter that is provided on Supplemental Table 5. 
What is shown on Figure 5 is the flowrate profile contour plot for the average of both half 
and full lower power. The profile shows a range of flow rate from a minimum of 74 cfm at 
the bottom of the front panel opening to a maximum of 141 cfm at the top.  
 
Figure 5: Flow Rate profile of half and full blower power average on the front opening of 
the aerosol hood.  
 
The flowrate is higher on the top of the hood based on the opening proximity to the 
filter location. The flowrate result confirms that there is a uniform airflow into the hood 
that will direct the patient's respiratory droplets to the HEPA filter and suctioned by the 
blower. Therefore, the HCWs are protected from aerosol-based disease transmission due 




The maximum velocity achieved from a full power blower setting resulted in 0.8 
mph (0.4 m s-1) velocity, which correlated with a Beaufort number of zero for an air speed 
less than 1 mph as shown in Figure 6 below. This indicates that the air speed is a calm wind 
where smoke rises vertically with little drift.  
Figure 6: Beaufort number to estimate wind speed and its visual clues [27]. 
Similar analysis of the noise level was conducted as the air flow speed. The noise 
level inside the hood is also important for the patient to not be disrupted by the high level 
of noise.  The noise level outside the hood impacts HCWs ability to communicate with the 
patient and with one another. For the outside the hood, the sound measurement indicated a 
maximum noise level of 64.3 dBA, which is a 2.7% increase from the blower off testing 
condition as a negative control for a half power blower setting (See Figure 7 below). A full 
power blower setting resulted in a maximum noise level of 81.5 dBA, which is 23.3% 
increase from the blower off testing condition. The minimum and average noise level data 





Figure 7: Maximum Noise level inside and outside of the aerosol hood using a sound 
measurement tool.  
 
The results shown on Figure 7 above are in the range of safe sound levels except 
the full power inside the hood. According to the National Institute for Occupational Safety 
and Health (NIOSH), the recommended noise exposure limit is below 85 dBA as shown 
on Figure 8 below [36]. 60 dBA is a normal conversation and 70dBA is vacuum cleaner 
noise level [Suppl. Figure 3], which will be what a patient side the hood will experience 
with a half power blower speed. In the meantime, the outside of the hood noise level 
between blower off and half blower is less than 5%, which causes no barriers as HCWs 




higher protection efficiency, we recommend a half power blower setting that has sufficient 
protection efficiency and allowable noise level.  
 
Figure 8: The recommended exposure limit of noise levels by NIOSH [36]. The half power 
blower setting is well under the exposure limit, while the full power blower setting nears 
the exposure limit. 
 
Overall, the flow rate profile and sound measurement confirm that the aerosol hood 




3.4.2. Air Exchange Time 
Figure 7 displays plots of raw data particle concentration versus time for both the 
research laboratory and M Simulation laboratory measurements.  The Research Lab 
(Figure 7c) was characterized by a rapid drop of the particle concentration from a maximum 
of 60,000 cm-3 particle concentration. This is due to the research laboratory set up had an 
aerosol outlet tube directly in the hood that avoided delay in the time effects of the aerosol 
reaching the measurement system. Meanwhile in the M Simulation Lab (Figure 9a and 9b), 
the aerosol outlet tube was connected to the abdomen of the Sim-Man and had to travel 
through the esophagus and reach the mouth opening causing a delay, which is more 
representative what would be expected if the users of the hood choose to test its efficacy 
in a hospital setting, without the ability to automate the process as in an aerosol research 
laboratory. In addition, two different particle sizers (CPC and OPS) and two different 
aerosol generators (API and BLAM Nebulizer) were used for the Research Lab and M 
Simulation Lab.   
The normalized particle concentration versus time was plotted for the M 
Simulation Lab as shown on Figure 10. The plot shows a gradual negative slope of the 
particle concentration reduction for approximately 60 seconds (1 minute). Unfortunately, 
similar type of graph could not be made for the Research Lab due to its rapid decrease, a 
single point measurement was performed to achieve the equivalent slop value (i.e. the 
condensation particle counter response time is not fast enough to accurately infer the 
concentration decay in the research lab setting). For the research lab the air changes time 






Figure 9: Raw data particle concentration clearance in the hood as a factor of time resulting 
in gradual negative slope for graph 9a and 9b, and rapid negative slope for graph 9c. (a) M 
Simulation lab set up half power, (b) M Simulation lab set up full power, and (c) Research 






Figure 10: Normalized particle concentration (with a negative slope for the first 60 






Table 1: Air change time and ACH for aerosol hood resulting higher than the 
recommended CDC guidelines. 
 
 
For the M Simulation lab, the negative slope was calculated from the graphs of 
Figure 10 above to calculated for the Air change time in minutes and ACH. Our results 
show the aerosol hood has an air exchange time of 2.76 minutes in average, even 
accounting for user error in measurement, with an average ACH of 151.44.  The 2003 CDC 
guidelines for infection control tabulate airborne contamination removal times for an ACH 
(Air Change per Hour) is listed on Supplemental Table 6 in Appendix B. For 99.9% 
reductions, with ACH from 10 – 15, 28 – 41 minutes are required in a hospital setting and 
the results shown on Table 1 above for the aerosol hood exceeds the guideline requirement. 
Therefore, by confining aerosol release events to small volume and actively clearing such 
volume, we can greatly reduce the wait time between operating room procedures, as 
effectively no aerosol release event occurs in the first place. The aerosol hood hence not 
only reduces the risk of infection transmission per the flowrate profile results, but also 




3.4.3. Particle Penetration 
High ACH and correspondingly reduced air change time are driven by the high 
flow rate to enclosed ratio of the aerosol hood.  It is equally important to examine 
penetration of particles from inside to outside.  Though certainly linked to the ACH, 
penetration, which is the ratio of outside particle concentration to inside particle 
concentration while the aerosol and blower are turned on, is also dependent on the quality 
of the filter used and the aerosol remaining leak tight aside intentional openings.  Tables 1 
and 2 below shows the raw data of particle concentration (dN/dlogDp) for inside and 
outside of the hood while the aerosol and blower turned on (negative pressure system 
running). The full blower power (Table 2) has more difference between the inside and 
outside particle concentration resulting in higher penetration value. Depending on the flow 
streamlines, the center and right measurement locations had higher particle concentration 
compared to the left and front measurement locations. For comparison, Background (BG) 
measurements were taken outside of the hood with no aerosol generation, but the blower 
turned on. The measurement between BG outside the hood with aerosol off and with 
aerosol on were so close to one another slightly higher reading while the aerosol is turned 
off. This is due to the aerosol generated during aerosol turned on is negligible compared to 
the number of particles in a non-clean room, it is difficult to pick up clear difference 
whether the aerosol is turned on or off. This negligible level of aerosol production is 






Table 2: Half blower power particle concentration by Diameter size. BG O(off) = 
Background Outside of the hood, aerosol turned off, blower on. O (on) = Outside of the 
hood with aerosol and blower turned on. I(on) = inside of the hood with aerosol and blower 





















Table 3: Full blower power particle concentration by Diameter size. BG O(off) = 
Background Outside of the hood, aerosol turned off, blower on. O (on) = Outside of the 
hood with aerosol and blower turned on. I(on) = inside of the hood with aerosol and blower 
turned on.  
 
Using the above O (on) and I(on) data, the particle penetration results were 10-4 to 
10-5 for a half power and 10-5 for the full power for particle size between 0.5 – 3.0 𝜇m 
(Figure 8). The 10-4 (half power) and 10-5 (full power) particle penetration resulted in 
99.99% and 99.999% protection efficiency (protection efficiency = 1- particle penetration) 
of the HEPA filter, respectively. The previous aerosol hood design resulted in particle 
penetration around 10-3 to 10-4 for particle size of 0.1 – 0.5 um [24]. Although the particle 
sizes were different between the two studies, this indicates that the protection efficiency 




Figure 11:  Particle penetration results of half and full blower power setting.  
Since the full blower power has higher noise that is safe but too loud for normal 
noise level, we recommend using half blower power with a 99.99% protection efficiency, 
which is still higher than the standard 99.9% aerosol reduction guideline from CDC [28]. 
3.5. Conclusions 
The aerosol hood design has been optimized based on physicians and HCWs feedback. 
The optimized aerosol hood design performance was assessed by measuring the 
characteristics of the flow rate profile, sound measurement, air exchange time and particle 
penetration. The two testing conditions were half power (Setting 4) and full power (Setting 
8) of the blower. The flow rate was measured using a grid type equidistance velocity 
measurement. The air exchange time was calculated from the slope of particle 
concentration vs. elapsed time plot to achieve the 99.9% aerosol reduction. The particle 




the hood when the aerosol generation and blower were both turned on. The following 
conclusions were drawn: 
1. The maximum flow rate with the full power blower setting was 0.8 mph (0.4 m/s), 
which is at the level of Beaufort Number 0 for calm air speed. The maximum sound 
measurement for half power blower speed inside the hood is 73.7 dBA, which is near 
a vacuum cleaner noise level and under the NOISH recommended noise exposure limit 
of 85 dBA.  Outside of the hood, the noise level is 64.3 dBA, which is near the 
conversation speech level of 60dBA. The optimized aerosol hood design provides a 
uniform air speed and safe noise level inside the hood with a half power blower setting.  
2. The aerosol hood has an average of air exchange time of 2.76 minutes and an ACH that 
is 151.44 on average for 99.9% reduction in M Simulation Lab. The true air exchange 
rate, however, is much faster than this, but difficult to quantify due to the slow time 
response of aerosol measurement instruments in comparison to the air exchange time.  
The aerosol hood effectively contains the aerosol generated within the hood and results 
in higher air change rates. Therefore, this result shows the potential of eliminating wait 
time between procedures for the 99.9% reduction time and increase hospital’s capacity 
to provide for more patient care. The aerosol hood not only reduces the risk of infection 
transmission towards HCWs but can enable improved care through increasing the 
number of procedures per day in a hospital network. 
3. The recommended half power blower setting has a particle penetration of 10-4 for a 
particle size range of 0.5 – 3.0 𝜇m. This particle penetration results in a protection 




protection efficiency of 99.99% combined with an average air exchange time of 2.76 
minutes, gives confidence in protecting HCWs from disease transmitting aerosols such 
as COVID-CoV-2 virus.  
3.6. Supplementary information  
List of information available in Appendix B: 
- Sound measurement of the hood and level of noise exposures in Table S1 and 
Figure S1 
- Flow rate measurement using equidistance locations and Log Tchebycheff fraction 
of duct inner diameter from Table S2 to Table S5 
- Air changes/hour (ACH) and time required for airborne-contaminant removal by 
efficiency in Table S6 











Chapter 4: Simulated Intubation Procedure in a 
Simulated Hospital Setting to Assess Exposure in a 
Room and Deposition on HCWs’ PPE 
4.1. Preface 
PPE, training, and hospital ventilation systems (including high air change rates and 
negative pressure rooms) are the common controls for protecting Health Care Workers 
(HCWs) from disease transmitting aerosols such as the SARS-CoV-2 virus. The objective 
of this study is to assess the aerosol hood technology efficacy as an additional engineering 
control for both hospital room ventilation and HCWs PPE. A simulated intubation 
procedure was conducted in a simulated hospital setting with 4 participants (currently 
registering 6 more participants). Participants performed the simulated intubation on a SIM-
man who is connected to aerosolization mixture of fluorescien dye with glycerol and DI 
water. The aerosol exposure was evaluated by taking particle concentration measurements 
in two locations in the room: next to the SIM-man by the bedside and in the corner of the 
room as a background. The particle deposition was evaluated by using fluorescein dye in 
the generated aerosol and collected on tape substrates that were placed on participants PPE 
(face shield, gloves, and gowns). In both cases evaluations testing conditions were 




Because of aerosol continuously released from the mouth of the Sim-Man, the 
aerosol exposure by the bedside had a 5 times higher particle concentration than the 
background location in the absence of hood. With the Blower On testing condition, the 
particle concentration by the bedside reduced by 78% for all participants compared to 
Blower Off and Baseline testing conditions. Particle deposition on a face shield and gowns 
had a 42% decrease for all participants in compared to the Baseline testing. However, the 
gloves had 32% higher particle deposition when compared to Baseline testing. The 
intubation and overall procedure time were tracked manually and using video footage. 
There was no statistical difference (p-value 0.685) among the testing conditions except a 
30 second increase for the use of aerosol hood when compared to the Baseline testing. 
Physicians were interviewed on their feedback regarding the aerosol hood technology use 
and their feedback are 1) the potential for the aerosol hood negative pressure in being used 
in clinical use and physicians adjusting to it 2) a continuous improvement need on the 
aerosol hood design in making it ergonomically friendly to give more hand flexibility and 
account for challenging intubation procedures. 
Overall, the localized negative pressure system of the aerosol hood has a potential 
in reducing the wait time for 99.9% aerosol reduction in a hospital room. The physical 
isolation property of the aerosol hood would protect HCWs PPE from experiencing high 
deposition. The amount of particle deposition varies from participant to participant based 
on their intubation procedure practice, therefore, PPE, especially gloves are still critical 




viruses such as SARS-CoV-2, outweighs the concerns of the minimal increase in procedure 
time and adaptation of a new technology.  
4.2. Introduction 
HCWs use three protection methods to control risk of disease transmitting aerosol 
exposure that are PPE, training, and the hospital ventilation system, including negative 
pressure rooms, and the high air change rates in operating rooms. According to CDC 
Hierarchy of Controls, PPE and training are the least effective forms of controls [11]. The 
introduction of the aerosol hood as an engineering control is one level higher than PPE and 
Training. Although the presence of an aerosol hood does not eliminate the need for proper 
PPE use and training, it provides a physical isolation and a negative pressure system as an 
additional control to relief from PPE side effects such as skin injury and headache [33-35].  
The aerosol hood not only enhances the current use of PPE and Training, but also 
improves the hospital ventilation system. The current hospital ventilation system Air 
Change per Hour (ACH) can often take 15 minutes or more to achieve 99.9% aerosol 
reduction. In Chapter 3, a localized negative pressure system of the aerosol hood can 
achieve the same percentage of aerosol reduction in less than 4 minutes, which has the 
potential to significantly decrease the wait time in between aerosol generating clinical 
procedures. 
To quantify the aerosol exposure control measures, a simulated intubation 
procedure clinical study was conducted with 4 HCW participants (registering 6 more 




particle concentration of the simulated hospital setting was analyzed by elapsed time and 
categorized by the three study conditions (i.e.  Baseline, Aerosol Hood with Blower Off 
and Aerosol Hood with Blower On). A piece of tape was placed on participants’ PPE such 
as the face shield, gloves, and surgical gown to quantify the aerosol deposition using a 
fluorescein dye marker. Duration of the intubation time and overall procedure time were 
also tracked to compare time difference with and without the aerosol hood. The last step of 
the clinical trial was an interview with the participants on their use experience and feedback 
for future design improvement. Based on such practical user experience, a continuous 
improvement can be made to achieve an effective ergonomic design that facilitates the 
adaption of the aerosol hood technology.  
 
Figure 1: Clinical trial of simulated intubation procedure being conducted in a simulated 




The clinical trial enabled a collaboration between engineers and physicians for a 
common cause of improving the development of aerosol hood technology and promoting 
early adaptors for more use of the aerosol hood in hospitals. Such collaboration of the 
primary user at the early stage of technology prototype and development facilitates the 
translation of clinical research to a practical product. According to the NASA Technology 
Readiness Level [30], there are nine levels of technology; where level 1 – 3 are early 
research, level 4 – 6 are technology development and level 7 – 9 technology ready for use 
as products (see Figure 2). In our case, early research (Level 1-3 is) is understanding 
aerosol science and conducting experiments to prove feasibility of the scientific findings. 
Most of academia work is at the level of technology in understanding through research and 
establishing science and early engineering principles. Technology development (Level 4-
6) is when the well-research knowledge with promising prototypes/feasibility data is 
translated into an iterative developmental phase to understand the engineering principles 
relation to performance of the technology. The last developmental phase of technology 
ready to launch (Level 7-9) is a manufacturing step in scaling up production of the 
technology without compromising the performance of the technology. The aerosol hood is 
at a level of 4 – 6 where the basic science and engineering principles have been proven and 






Figure 2: Leveraging NASA’s technology readiness level to assess the development phase 
of the aerosol hood technology [30]. 
 
The benefit of the aerosol hood by providing an isolation and filtration of infectious 
aerosols and increased throughput of clinical procedure, outweighs the risk of adopting 
new technology, time added to incorporate to standard use.  
4.3. Experimental Methods 
HCW Participants: After IRB protocol (#STUDY00012371) approval for medical study 
clinical trial, recruitment emails were sent to the respiratory therapy, pulmonary, and 
critical care divisions to recruit 10 volunteers in participating in the clinical study. At the 
time of writing this thesis, only 4 participants completed the study and in the process of 
registering 6 more participants to complete the clinical study. The inclusion criteria were 
HCWs who performed intubation as part of their regular work activities (and are licensed 




participants before starting the study and participants were able to watch a training video 
prior to the study. At the end of the study, participants had an interview with a health 
science professional on their use of aerosol hood and feedback for future improvements. 
Simulated Hospital Setting Set Up: Participants went through a PPE donning procedure of 
wearing a surgical gown, face shield and gloves prior to the study testing. A substrate 
(masking tape with 1in2) was placed on their PPE and inside of the aerosol hood, as shown 
in Figure 3 below. A 50 g/L Uranine powder was mixed with DI water to achieve 5% 
Uranine concentration by weight to form the fluorescein dye. A solution of 5% fluorescein 
dye mixed with 20% Glycerol and DI water was used to generate aerosol using a BLAM 
Nebulizer. One side of the Nebulizer was connected to that non-humidified compressed air 
at a pressure of 30 psi resulting in 15 L/min flow rate of aerosolization. And the other side 
of the Nebulizer was connected to the SIM-Man (Manikin) through the esophagus as it is 
illustrated on Figure 3 below.  
Figure 3: Substrate of a masking tape placement location on the outside and inside the 
aerosol hood. 
 
Simultaneously, the particle concentration in the simulated hospital setting was 




the simulated hospital setting as a background (See Figure 4 below). The bedside particle 
counter represented HCWs usual standing place as they took care of the patient. The 
background particle counter was as a sample on how far the particles would be spreading 
around the room during testing. 
 
Figure 4: Simulated hospital setting for the clinical study in the UMN M Simulation Lab. 
(BG = Background, OPS = Optical Particle Sizer) 
 
The simulated hospital room was 20.3 ft x 15 ft x 10 ft (3050 ft3, or 86.4 m3) had 
an air scrubber (Electrocorp Air Rhino Jr 9975 Carbon/HEPA Air Scrubber) with a 
maximum of 735 cfm running the whole time of the test conditions to minimize the room 
particle count. The ACH in the room is 2.5 from the ventilation system, but the total ACH 
combining the recirculating scrubber was 2.5 + 735 cfm x 60 min/hr /3050 ft3 = 17, beyond 
the 10-15 observed in many hospital settings. It is important to note not all hospital settings 
















skewed in a high particle number concentration room.  However, that was not the case in 
this study because of the additional portable ventilation utilized.   
Testing Conditions: There were three testing conditions with each participant and each 
testing had three replicates. The first testing was a baseline intubation procedure without 
the use of the aerosol hood. The second testing was a simulated intubation procedure using 
the aerosol hood but without using the blower (Blower Off), therefore, the aerosol hood is 
acting merely as a physical isolation. The third testing was a simulated intubation 
procedure using the aerosol hood with the blower (Blower On) that created the negative 
pressure system. The two OPS machines were measuring particle concentration for 
replicates of each testing condition (3x3 samplers per participant). After each testing 
conditions, the tape substrates were collected and participants replaced their gloves for the 
next testing, while keeping the same gown and face shield.   
Participants followed a protocol of a 7-step intubation procedure (see Supp. Figure 
1) to standardize practices and reduce variations. The intubation procedure is one of the 
highest aerosol-generating clinical procedures and risky to HCW as they need to get in 
close contact with the patient and place a tube inside an airway through the throat [1].  
Substrate preparation for fluorescence measurement: The participants’ tape substrates 
were removed from the PPE and placed into a petri dish after every test condition. A 
solution of 3ml Sodium Hydroxide (NaOH) was added to the sample tapes in the petri dish 
to dilute the fluorescein dye particles with Sodium Hydroxide. The diluted solution was 
then transferred to a glass vial for fluorescein concentration measurement using Sequoia-




face shield (Sample 2) substrates were measured separately but pulled together for analysis 
as an ‘Outside the Hood Exposure’ and the inside of the hood (Sample 3) and gloves 
(Sample 4) substrates were measured separately but pulled together for analysis as an 
‘Inside the Hood Exposure’. 
fluorescein measurement: SC515/NB490 wavelength fluorescein reader was inserted into 
the Sequoia-Turner Model 450 Fluorometer. The fluorometer is calibrated before 
measurement by first setting the desired ‘gain’ value. Then, using a known zero 
concentration sample vial to zero out the reading followed by setting the ‘span’ value to 
1200 using a known fluorescent concentration. Then the vial samples are tested and the 
value from the Fluorometer is divided by the gain value for correction. Then the data is 
normalized by dividing the corrected value by the total area of the tape used per sample (a 
single tape had an area of 1in2 (6.45cm2). 
4.4. Results and Discussion 
4.4.1. Aerosol exposure in a simulated hospital setting 
The aerosol exposure in a simulated hospital setting was assessed by measuring the 
particle concentration during participants conducting a simulated intubation procedure. 
The particle concentration measurements were taken in two locations: by the bedside and 
at a corner of the room as a background. For all participants, the bedside location particle 
concentration (~ 7000 #/cm3) was 5 times higher than the background location (~1450 




Blower On and Blower Off testing conditions near to the patient by the bedside. The 
Blower On testing, where the aerosol hood was on the SIM-man and the negative pressure 
system was running, the total concentration remained less than 1000 particles/cm3 
compared to the Baseline and Blower Off testing. The Blower Off testing, where the 
aerosol hood was on the SIM-man without the negative pressure system running, the 
physical isolation of the aerosol hood has been able to delay the maximum particle 
concentration approximately 10-15 sec from the Baseline. In the case of participant 4, the 
Blower Off maximum particle concentration was delayed by over one minute. This is 
because during the 1-minute preoxygenation step of the intubation, the participant was 
squeezing on an air bag for one minute (the other participants were not) that might have 
disrupted the airflow direction. The Baseline testing represented the current standard of 
intubation with direct contact with the patient without the isolation of the aerosol hood or 








Figure 5: Bedside particle concentration measurement to assess the aerosol exposure 
during the Baseline, Blower On and Blower Off testing of a simulated intubation 
procedure. The Blower On testing resulted in much lower particle concentration than the 
Baseline and Blower Off testing. The Blower Off testing resulted in the delay of the 






Figure 6: Background particle concentration measurement to assess the aerosol exposure 
during the Baseline, Blower On and Blower Off testing of a simulated intubation 
procedure. All testing resulted in much lower particle concentration than the Bedside 
measurement. Similar to Figure 5, the Blower On testing resulted in being lower than the 
other two testing conditions (Blower Off and Baseline). 
 
 
While Figure 5 showed the bedside particle concentration during intubation 
procedure time, Figure 6 shows the background particle concentration during the same 
procedure time. At a far distance from the SIM-man, all participants testing conditions 
resulted in a much lower count of the particle an average of 1000 #/cm3 than the Bedside 
particle concentration of an average nearly 5000 #/cm3. For the bedside measurement, the 




when Blower On as shown in Figure 7 below. This result confirms the effectiveness of the 
aerosol hood negative pressure system ability to reduce risk of aerosol exposure in the 





Figure 7: Comparison of Bedside and Background maximum particle concentration in a 
Simulated Hospital Setting of all participants. The Blower On for Bedside comparable to 
the Background particle concentration showing the effectiveness of the aerosol hood 





In addition, due to the localized aerosol containment and filtration of the aerosol 
hood, the existing hospital ventilation system can be enhanced in achieving the 99.9% 
aerosol reduction time faster than the current 15 minutes, nominal average in many hospital 
settings. Therefore, with the introduction of aerosol hood technology for aerosol generating 
procedures, a typical surgery room wait time can be reduced and more procedures can be 
done.  
4.4.2. Particle Deposition on HCW’s PPE 
Other than the simulated hospital setting, the clinical study also tested the particle 
deposition on HCW’s PPE. PPE is the primary form of protection for HCWs for aerosol 
related transmission disease control [9, 10, 13, 14, 15], consequently, understanding how 
the aerosol hood technology affects the PPE use is important. The three PPE used in this 
study were face shield, gloves, and surgical gowns. The face shield and surgical gowns 
were considered outside of the hood deposition measurements. The gloves were considered 
inside of the hood. Figure 8 shows the fluorescein deposition for Blower Off inside the 
hood was the highest with an average of 2.87 ug/cm2 and the Blower On outside of the 
hood was the lowest with an average of 0.94 ug/cm2 for all participants. For participle 
deposition, the physical isolation of the aerosol hood has a larger role than the Blower 






Figure 8: Each participant’s fluorescein deposition inside and outside of the aerosol hood 
for the testing of Baseline, Blower On and Blower Off. Blower Off inside the hood has the 
highest deposition and Blower On outside of the hood has the lowest deposition.  
 
Figure 9: All participant’s fluorescein deposition inside and outside of the aerosol hood 
for the testing of Baseline, Blower On and Blower Off. Inside the hood has the highest 
deposition than the Baseline testing. Outside of the hood has the lowest deposition than the 





Outside of the hood whether it is Blower On or Off, the deposition results were 
lower by 42% from the Baseline testing, which is another strong indication of the physical 
isolation property of the aerosol hood protects the HCW’s from being exposed to aerosols 
on their gowns and face shields. 
Inside of the hood for Blower On and Off testing conditions, the deposition results 
were higher by 32% from the Baseline testing, indicating the importance of PPE, especially 
gloves. The particle deposition is a product of fluid velocity, number of particles, area of 
substrate and procedure time. With the physician isolation of the aerosol hood, the velocity 
and number of particles are going to increase resulting in a high deposition amount. 
Therefore, the use of an aerosol hood does not negate the need for proper PPE, especially 
the use of gloves.  
 
4.4.3.  HCW Performance and Feedback 
 
The intubation and overall procedure time were tracked to assess any differences 
due to the use of aerosol hood. Figure 10 shows that the average and median simulated 
intubation time was 20 seconds and the average and median overall intubation procedure 
time was 2 minutes across all testing with and without the aerosol hood. The results are 
promising that this is not a significant addition of time for using the aerosol hood. 
Participant 4 ‘Baseline replicate 1 testing’ took an extra time to select the right tools during 





Figure 10: Time record of the simulated intubation and overall procedure time of all 
participants for each testing of Baseline, Blower On and Blower Off. Overall no significant 








Figure 11A. All participants time of intubation that is the time it took to access airway 
using intubation tools was around 20 seconds.  
 
Figure 11B. All participants overall intubation that includes the oxygenation, intubation 
and the use of aerosol hood was around 2 minutes in average and 30 seconds higher for the 






Without including the Participant’s 4, Baseline 1 into the Boxplot of Figure 11A 
and 11B above, the overall duration of the procedure time, the Blower On testing has a 
maximum of  34 seconds faster than the Baseline testing and statistically insignificant with 
a p-value of 0.689 with a 2 sample t-test. Furthermore, considering the benefit of lowering 
the risk of disease transmitting aerosols by using the aerosol hood as an engineering control 
along with PPE, a 30-second procedure time increase should be tolerable.  
The intubation time can also be correlated with the particle deposition on the PPE, 
where we can hypothesize that the longer the intubation time it takes, the higher the 
fluorescein deposition on the PPE. Figure 12 below shows the correlation between the 
intubation time to fluorescein deposition for outside of the hood PPEs such as face shield 
and shoulders. The results show an overall trend of higher deposition for higher procedure 
time. On the contrary, the Blower On testing for the duration of intubation time shows 
lower deposition for all testing conditions especially when compared with Baseline. This 










Figure 12: Correlation between the intubation procedure time and fluorescein deposition 
outside of the aerosol hood of all participants. A general trend of longer procedure time 




The above study results show the effectiveness of the aerosol hood in minimizing 
aerosol exposure in a simulated hospital setting, HCW’s PPE outside of the hood and 
similar duration of procedure time between aerosol hood and Baseline testing. The final 
step was to get physicians feedback on their use of the aerosol hood and suggestions for 
future improvement. In Figure 13, at least 3 out of 4 participants gave feedback on the 
potential of the aerosol hood in being able to be adjusted and strategized and it is practical 
for clinical use. They also commented that the hood/box felt constraining and being 
challenging for difficult airways.  
 
Figure 13: Total of 4 Participants’ feedback on the aerosol hood during exit interview as 





The participants’ feedback is a confirmation of the aerosol hood at the level of 4-6 
technology readiness. The results show a continuous improvement of the aerosol design 
box is needed to make it more ergonomically compatible. In the meantime, the performance 
of the HEPA filter and negative pressure system's ability to capture respiratory droplets is 
appreciated as an engineering control to protect HCWs.  
4.5. Conclusions 
In a simulated hospital setting, a simulated intubation procedure was conducted to study 
the impact of aerosol hood technology on hospital ventilation system, HCW PPE and 
physician’s performance. To assess aerosol exposure in the hospital setting room, 
maximum particle concentration was measured by the SIM-Man bedside location and at a 
corner of the room as a background location. The particle deposition was analyzed by 
placing tape substrate on participant’s PPE and using fluorescein dye in the solution for 
aerosolization. The intubation and procedure time were tracked manually and by video 
footage and participant’s feedback were analyzed after the intubation procedure was 
completed in an exit interview session. The following conclusions were drawn: 
1. The localized aerosol hood technology over the patient’s respiratory droplets has the 
potential to enhance the standard hospital ventilation system because of the negative 
pressure system. The results show a Blower On setting by the bedside location is 78-
80% lower particle concentration than the Blower Off and Baseline testing. In addition, 
the background location for all testing has an average of 1000 #/cm3 particle 




ACH wait time of 15 minutes to achieve 99.9% aerosol reduction time can be greatly 
reduced using aerosol technology that effectively localize aerosol dispersion due to the 
negative pressure system. 
2. The physical isolation aspect of the aerosol hood technology reduced the particle 
deposition on PPEs such as face shields and gowns by 42% from the Baseline testing. 
The containment of the aerosol inside the hood indicates its efficacy in protecting 
HCWs exposure to disease transmitting aerosols. However, PPE such as gloves are still 
primary protection from particle deposition as the data inside the hood shows an 
increased deposition by 32% from the Baseline testing. The aerosol hood technology 
does not eliminate the use of PPE and Training as a control, but it is an additional 
engineering control in containing respiratory droplets from patients. 
3. There was no statistical or significant difference between baseline and aerosol hood use 
for overall intubation procedure time with p-value of 0.689 with a 2-sample t-test. This 
data indicates the use of this new technology is not going to add a significant amount 
of procedure time. Given the benefit of additional protection to HCWs, adapting the 
aerosol hood technology is highly recommended. 
4. Participants’ feedback highlights the positive side of the aerosol hood in its potential in 
providing a negative pressure system in capturing respiratory droplets. Also, an 
opportunity for design improvement of the aerosol hood design in making it 





3.7. Supplementary information  
List of information available in Appendix C: 
- Standardized intubation procedure for the clinical study in Figure S1 
- Bedside and background exposure replicate data of total particle concentration for 
each participant from Figure S2 to Figure S9 





























Chapter 5: Conclusions and Future Directions 
SARS-Cov-2 virus appears to be a long-term occurrence that will require a more 
efficient way of protecting HCWs now and in the future. The current method of PPE, 
training and hospital’s ventilation system will not be long term sustainable protection 
considering the side effects such as headache, skin injury and inconsistent donning and 
doffing procedures. There is a clinical unmet need for an engineering control such as 
aerosol hood that will alleviate a dependence on current controls. Literature shows that the 
current aerosol boxes and containment devices are not as advanced in development as the 
aerosol hood presented in this thesis. To continue improving the aerosol hood, 
understanding the droplet trajectory, and getting HCWs feedback has been instrumental.  
Chapter 2 dealt with modelling isothermal jet model to understand the respiratory 
droplets trajectories with a head tilt angle and residence time of droplets as a function of 
evaporation and settling rates. These aerosol principles are critical inputs in redesigning 
the aerosol hood and assessing the performance of the design. Some of the important results 
obtained from this study are: 
1.  The 62-cfm flow rate of the half power blower setting of the aerosol hood, would be 
able to clear small droplets below the critical diameter size of 65 μm in the air flow 
streamline. Large droplets will be cleared in two ways; a) staying in the jet path and 
impacting on aerosol hood. b) evaporation to small sizes which are easily transported to 




2.   The evaporation and settling curve shows a critical diameter size of 65 μm at a time of 
30 seconds. For smaller diameters the evaporation rate is within few seconds, which will 
be cleared again by the 62-cfm half power blower setting of the aerosol hood.  
Based on the research described in Chapter 2, the following issues may be investigated in 
the future: 
1. Modeling that simulated the breathing pattern and accounting for the thermal 
plume in droplet transport modeling. 
2. Considering the aerosol hood itself in flow modeling. 
3. As more is learned about rates of droplet and particle production by human 
respiratory activities and about the concentrations of viable viruses in such 
particles, more detailed exposure models can be developed using trajectory 
modeling. 
Chapter 3 dealt with the optimized aerosol hood design performance by evaluating 
the flow rate profile, level of noise, air exchange time and particle penetration. The negative 
pressure system at the half power blower setting resulted in high performance and potential 
in the aerosol hood as an engineering control by achieving aerosol reduction of 99.9%. 
Some of the important results obtained from this study are: 
1. The maximum flow rate with the full power blower setting was 0.8 mph (0.4 m/s), 
which is at the level of Beaufort Number 0 for calm air speed. The maximum sound 
measurement for half power blower speed inside the hood is 73.7 dBA, which is near 




of 85 dBA. The optimized aerosol hood design provides a uniform air speed and safe 
noise level inside the hood with a half power blower setting.  
2. The aerosol hood has an air exchange time of average of 2.76 minutes for an ACH that 
is 151.44 on average for aerosol reduction of 99.9%. The aerosol hood not only reduces 
the risk of infection transmission towards HCWs, but also increases the hospital’s 
capacity to provide more patient care. 
3. This particle penetration resulted in 10-4 with a corresponding protection efficiency of 
99.99%. The optimized aerosol hood design performance by HEPA filter protection 
efficiency of 99.99% combined with high air exchange time of 2.76 minutes, gives 
confidence in protecting HCWs from nosocomial infection. 
Based on the research described in Chapter 3, the following issues may be investigated in 
the future: 
1. Further design refinement to improve device ergonomics, reduce weight, and 
ideally, incorporate directly into hospital’s ventilation systems or beds. 
2. Development of a battery-operated model for use in emergency settings. 
3. Development of a “foldable” model for ease of storage. 
Chapter 4 dealt with the IRB approved clinical trial results in aerosol exposure 
during a simulated intubation in a simulated hospital setting and particle deposition on 
HCWs’ PPE.  In addition, assessed the impact of the aerosol hood on the participants 
intubation time and user experience compared to baseline intubation as a control. The 




the potential of the aerosol hood for practical clinical use. Some of the important results 
obtained from this study are: 
1. The localized aerosol hood technology over the patient’s respiratory droplets enhances 
the standard hospital ventilation system because of the negative pressure system. The 
results show a Blower On setting by the bedside location is 78-80% lower particle 
concentration than the Blower Off and Baseline testing. In addition, the background 
location for all testing has an average of 1000 #/cm3 particle concentration, which is 5 
times lower than a bedside location. The current hospital ACH wait time of 15 minutes 
to achieve 99.9% aerosol reduction time can be greatly reduced using aerosol 
technology that effectively minimizes aerosol exposure due to the negative pressure 
system. 
2. The physical isolation aspect of the aerosol hood technology reduced the particle 
deposition on PPEs such as face shields and gowns by 42% from the Baseline testing. 
The containment of the aerosol inside the hood indicates its efficacy in protecting 
HCWs exposure to disease transmitting aerosols. However, PPE such as gloves are still 
primary protection from particle deposition as the data inside the hood shows an 
increased deposition by 32% from the Baseline testing. The aerosol hood technology 
does not eliminate the use of PPE and Training as a control, but it adds protection as 
an engineering control. 
3. There was no statistical or significant difference between baseline and aerosol hood use 
for intubation time and overall procedure time with a p-value of 0.689 for 2-sample t-




significant amount of procedure time. Given the benefit of additional protection to 
HCWs, adapting the aerosol hood technology is highly recommended. 
4. Participants’ feedback highlighted the positive side of the aerosol hood in its potential 
future clinical use and in providing a negative pressure system in clearing respiratory 
droplets. Also, an opportunity for design improvement for ergonomically friendly 
aerosol hood to give more hand flexibility and account for challenging intubation 
procedures. 
Based on the research described in Chapter 4, the following issues may be investigated in 
the future: 
1.  With EUA approval for the aerosol hood recently issued.  Physicians could 
now use the device for intubation on patients and lead an actual human trial 
with it.  This would be highly similar in design to the simulation study, but 
rather than examine tracer particles, sampling for infectious particles during an 
actual procedure would be required.  This study would be a much larger 
undertaking than a simulation study, requiring coordination with a hospital 
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Figure S4: First step of calculating fluid velocity using Xie et al. [7] equations with an 
incorporated head tilt angle. 
 
 








Appendix B: (Supplementary material for Chapter 3) 
 
Table S1: Sound measurement inside and outside the aerosol hood with blower setting 
change.  
 
Speed Speed Location Min (dBA) Max (dBA) Average (dBA) 
Blower Off 
Blower Off Inside Center  51.3 54.9 53.1 
Blower Off Outside (right) 57.1 62.8 59.95 
Blower Off Outside (left) 56.5 61.7 59.1 
Blower Off Outside(back) 56.9 63.2 60.05 
Half Power 
Half Power Inside Center  71.0 73.7 72.4 
Half Power Outside (right) 59.3 62.2 60.75 
Half Power Outside (left) 67.9 68.6 68.25 
Half Power Outside(back) 60.9 62.2 61.55 
Full Power 
Full Power Inside Center  90.5 94.7 92.6 
Full Power Outside (right) 69.4 77.3 73.35 
Full Power Outside (left) 82.1 88.6 85.35 








Figure S1: Level of Noise (Source: Levels Of Noise In Decibels (dB) Level Comparison 






Table S2: Log Tchebycheff  fractions of duct inner diameter measurement for flow meter. 
 
 Depths Fraction of Inner Diameter Actual Depth 
Depth # 1 0.0 0.2 
Depth # 2 0.1 0.8 
Depth # 3 0.3 1.9 
Depth # 4 0.7 4.1 
Depth # 5 0.9 5.2 
Depth # 6 1.0 5.8 
      
Duct Diameter 6 inches   
Area (ft^2) 0.196   
 
Table S3: Flow rate measurement using Log Tchebycheff  fraction of duct inner diameters 
from Table S2. 
Location 
Average Velocity [ft/min] over an 




Position Depth 1/2 Power Full Power 1/2 Power Full Power  
Hole 1 Depth # 1 414.0 959.0 81.3 188.3  
Hole 1 Depth # 2 518.0 1074.0 101.7 210.8  
Hole 1 Depth # 3 511.0 1012.0 100.3 198.7  
Hole 1 Depth # 4 365.0 704.0 71.7 138.2  
Hole 1 Depth # 5 307.0 621.0 60.3 121.9  
Hole 1 Depth # 6 287.0 583.0 56.4 114.5  
Hole 2 Depth # 1 316.0 705.0 62.0 138.4  
Hole 2 Depth # 2 337.0 669.0 66.2 131.4  
Hole 2 Depth # 3 401.0 733.0 78.7 143.9  
Hole 2 Depth # 4 496.0 972.0 97.4 190.9  
Hole 2 Depth # 5 461.0 908.0 90.5 178.3  
Hole 2 Depth # 6 448.0 909.0 87.9 178.5  
Hole 3 Depth # 1 438.0 724.0 86.0 142.2  
Hole 3 Depth # 2 420.0 866.0 82.5 170.0  
Hole 3 Depth # 3 458.0 874.0 89.9 171.6  
Hole 3 Depth # 4 369.0 791.0 72.5 155.3  
Hole 3 Depth # 5 336.0 699.0 65.9 137.3  
Hole 3 Depth # 6 329.0 707.0 64.6 138.8  
Average 400.6 806.1 78.7 158.3  
   STD of DEV 14.3 28.2  












Flow Rate (cfm) 
When No Blower 
Power 
Flow Rate (cfm) 
When Half Blower 
Power 
Flow Rate (cfm) 
When Full Blower 
Power 
Top Left 0 1.42 9 77 162 
Top Center 1 1.42 6 102 122 
Top Right 2 1.42 43 79 210 
Middle Left 0 0.71 0 40 102 
Center 1 0.71 3 82 153 
Middle Right 2 0.71 40 68 122 
Bottom Left 0 0 9 23 128 
Bottom Center 1 0 28 57 85 
Bottom Right 2 0 11 34 113 





Table S5: Flow rate profile of the HEPA filter of the aerosol hood on top panel. 
Setting 4 Setting 8  
Velocity [ft/min] Flow Rate [cfm] Velocity [ft/min] Flow Rate [cfm]  
27 76.41 57 161.31  
36 101.88 43 121.69  
28 79.24 74 209.42  
14 39.62 36 101.88  
29 82.07 54 152.82  
24 67.92 43 121.69  
8 22.64 45 127.35  
20 56.6 30 84.9  
12 33.96 40 113.2  
     
Avg 62.26 Avg 132.6955556  
STD DEV 25.97594705 STD DEV 37.07312002  












Table S6: Air changes/hour (ACH) and time required for airborne-contaminant removal 
by efficiency [28] 
The number of air changes per hour and time and efficiency. 
ACH § ¶ 
Time (mins.) required for removal 
99% efficiency 
Time (mins.) required for removal 
99.9% efficiency 
2 138 207 
4 69 104 
6+ 46 69 
8 35 52 
10+ 28 41 
12+ 23 35 
15+ 18 28 
20 14 21 
50 6 8 







Figure S2: Background particle concentration measurement with the blower on and 




Appendix C: (Supplementary material for Chapter 4) 
 






Figure S2: Replicates of participant 1 bedside exposure total particle concentration. 
 
 

























Participant 1: Bedside Exposure
















































Participant 2: Bedside Exposure


































Participant 3: Bedside Exposure
























































Participant 4: Bedside Exposure
































Participant 1: Background Exposure





















Participant 2: Background Exposure




































Participant 3: Background Exposure





















Participant 4: Background Exposure



















































Figure S13: Participant 4 feedback on the aerosol hood 
 
 
 
 
 
 
 
 
